We are live on
!
Find out more
WSTAM
Wilbanks Smith & Thomas Asset Management Portfolio holdings
AUM
$3.57B
1-Year Est. Return
21.11%
This Fund
S&P 500
This Quarter
Est. Return
-5.19%
1 Year Est. Return
+21.11%
3 Year Est. Return
+25.24%
5 Year Est. Return
+75.04%
10 Year Est. Return
+189.02%
AUM
$2.33B
AUM Growth
-$49.1M
(-2.1%)
Cap. Flow
+$91.2M
Cap. Flow
% of AUM
3.91%
Top 10 Holdings %
Top 10 Hldgs %
37.85%
Holding
505
New
25
Increased
205
Reduced
137
Closed
37
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBonds Dec 2027 Term Corporate ETF
IBDS
|
+$52.3M |
| 2 |
Invesco BulletShares 2028 Corporate Bond ETF
BSCS
|
+$23M |
| 3 |
iShares iBonds Dec 2028 Term Muni Bond ETF
IBMQ
|
+$12.8M |
| 4 |
Invesco BulletShares 2027 Corporate Bond ETF
BSCR
|
+$10.9M |
| 5 |
Vanguard Intermediate-Term Treasury ETF
VGIT
|
+$10.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBDP
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
|
+$25.4M |
| 2 |
BSCO
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
|
+$21.1M |
| 3 |
BSCN
Invesco BulletShares 2023 Corporate Bond ETF
BSCN
|
+$16.3M |
| 4 |
iShares 3-7 Year Treasury Bond ETF
IEI
|
+$12.4M |
| 5 |
iShares Core 60/40 Balanced Allocation ETF
AOR
|
+$11.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.2% |
| 2 | Industrials | 6.96% |
| 3 | Healthcare | 5.98% |
| 4 | Financials | 5.47% |
| 5 | Consumer Staples | 3.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
401
Zebra Technologies
ZBRA
$18B
| $251K | 0.01% |
959
-10
| -1% | -$3.1K |
|
402
BridgeBio Pharma
BBIO
$16.6B
| $250K | 0.01% |
25,137
+41
| +0.2% | +$426 |
|
|
UCTT
403
Ultra Clean Holdings
UCTT
$3.79B
| $250K | 0.01% |
9,700
+1,800
| +23% | +$55.1K |
|
|
NID
404
DELISTED
NUVEEN INTERMEDIATE DURATION MUNICIPAL TERM FUND
NID
| $248K | 0.01% |
20,072
| – | – |
|
405
Nutrien
NTR
$31.9B
| $247K | 0.01% |
2,959
-1,287
| -30% | -$111K |
|
406
Mohawk Industries
MHK
$9.32B
| $246K | 0.01% |
2,699
+525
| +24% | +$60.9K |
|
407
Varex Imaging
VREX
$778M
| $245K | 0.01% |
11,600
+100
| +0.9% | +$2.19K |
|
408
Axalta
AXTA
$8B
| $244K | 0.01% |
11,600
| – | – |
|
409
eBay
EBAY
$47.5B
| $244K | 0.01% |
6,622
-11,728
| -64% | -$523K |
|
410
Carter's
CRI
$1.46B
| $242K | 0.01% |
3,695
+100
| +3% | +$7.66K |
|
|
INFN
411
DELISTED
Infinera Corporation Common Stock
INFN
| $242K | 0.01% |
49,900
+13,600
| +37% | +$74.6K |
|
412
Global X S&P 500 Covered Call ETF
XYLD
$3.28B
| $239K | 0.01% |
6,268
| – | – |
|
|
VTLE
413
DELISTED
Vital Energy
VTLE
| $236K | 0.01% |
3,750
| – | – |
|
|
HDV
414
iShares Core High Dividend ETF
HDV
$15B
| $233K | 0.01% |
12,780
+10
| +0.1% | +$202 |
|
415
Corning
GLW
$137B
| $230K | 0.01% |
7,911
-1,757
| -18% | -$59.5K |
|
416
Genuine Parts
GPC
$18.8B
| $230K | 0.01% |
1,542
-13,881
| -90% | -$2.1M |
|
417
Cullen/Frost Bankers
CFR
$10.4B
| $228K | 0.01% |
+1,726
| New | +$226K |
|
418
Ball Corp
BALL
$16.7B
| $226K | 0.01% |
4,681
| – | – |
|
419
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
| $226K | 0.01% |
11,000
| – | – |
|
420
Sunrun
RUN
$2.42B
| $226K | 0.01% |
+8,194
| New | +$255K |
|
421
iShares MSCI EAFE Value ETF
EFV
$30B
| $225K | 0.01% |
5,848
| – | – |
|
422
Celanese
CE
$4.95B
| $223K | 0.01% |
2,470
| – | – |
|
423
AstraZeneca
AZN
$247B
| $220K | 0.01% |
2,002
+160
| +9% | +$20.3K |
|
|
MRSH
424
Marsh
MRSH
$91.7B
| $220K | 0.01% |
1,472
-200
| -12% | -$32.1K |
|
425
Veeva Systems
VEEV
$38.6B
| $220K | 0.01% |
1,335
| – | – |
|
Similar funds
CW
ICG
CT
ZCM
CQS
SCM
AFIMH
DA
Wilbanks Smith & Thomas Asset Management's Q3 2022 Portfolio in Review
As of Q3 2022, Wilbanks Smith & Thomas Asset Management held 505 positions worth $2.33B, down 2.1% from $2.38B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Wilbanks Smith & Thomas Asset Management deployed $91.2M of net new capital in Q3 2022, opening 25 new positions and adding to 205 existing holdings. Its largest new stake was iShares iBonds Dec 2027 Term Corporate ETF: 2,187,499 shares worth $50.3M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.8% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares iBonds Dec 2024 Term Corporate ETF, an estimated $25.4M trimmed.
- Wilbanks Smith & Thomas Asset Management's largest Q3 2022 buy was iShares iBonds Dec 2027 Term Corporate ETF: 2,187,499 shares worth $50.3M.
- Wilbanks Smith & Thomas Asset Management added most to Invesco BulletShares 2027 Corporate Bond ETF in Q3 2022, an estimated $10.9M increase.
- Wilbanks Smith & Thomas Asset Management's biggest Q3 2022 reduction was iShares iBonds Dec 2024 Term Corporate ETF, cutting an estimated $25.4M.
- Wilbanks Smith & Thomas Asset Management fully exited iShares iBonds Dec 2022 Term Muni Bond ETF in Q3 2022, selling an estimated $3.65M.
- Wilbanks Smith & Thomas Asset Management's ten largest holdings make up 38% of its $2.33B portfolio in Q3 2022.
- Wilbanks Smith & Thomas Asset Management opened 25 new positions and closed 37 in Q3 2022.
- Wilbanks Smith & Thomas Asset Management's portfolio value fell 2.1% quarter-over-quarter to $2.33B.
Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q3 2022, filed 31 Oct 2022.